The sample size of TB patients with HIV co-infection was not large enough; thus, the power for evaluating the performance of CXCL10 mRNA release assay in this population was decreased, and further validation is needed in a larger sample size of HIV co-infected population. Here, CXCL10 is linked to coinfection.